Stay updated on Vilazodone Safety in GAD: Clinical Trial

Sign up to get notified when there's something new on the Vilazodone Safety in GAD: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vilazodone Safety in GAD: Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The banner announcing NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” was removed. The 403 error page content remains unchanged.
    Difference
    1%
    Check dated 2026-11-10T06:47:09.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0. The page continues to show a 403 Forbidden message.
    Difference
    0.2%
    Check dated 2026-11-03T03:26:59.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A site-wide banner announces an NIH website transition and says that “Super Intelligence” may appear in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-27T06:38:19.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer revision label was updated from v3.7.1 to v3.7.2 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-20T08:23:24.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.0 to v3.7.1, while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-13T08:18:05.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error page instead of the study record content, effectively making the NCT01844115 page inaccessible to users.
    Difference
    17%
    Check dated 2026-09-22T06:20:22.000Z thumbnail image

Stay in the know with updates to Vilazodone Safety in GAD: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vilazodone Safety in GAD: Clinical Trial page.